Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingCyclophosphamideHematopoietic Stem CellsHistocompatibilityMedical OncologyTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationCombined Modality TherapyHematopoiesisRecurrenceTreatment OutcomeRadiation ChimeraMice, Inbred C57BLLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsImmunosuppressive AgentsTime FactorsGraft RejectionHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionLymphoma, Non-HodgkinStem Cell TransplantationImmunosuppressionLymphocyte DepletionLeukocyte TransfusionSurvival AnalysisAcute DiseaseHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesMyelodysplastic SyndromesHLA AntigensOncology NursingHematologic DiseasesLung TransplantationActuarial AnalysisCyclosporineBone DensityLymphocyte TransfusionSurvival RateNuclear FamilyDisease-Free SurvivalFollow-Up StudiesCarmustineOrgan TransplantationCytarabinePancytopeniaGraft vs Tumor EffectCell DifferentiationLeukocyte CountGraft vs Leukemia EffectEtoposideCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorMelphalanBone ResorptionSpleenMice, Inbred BALB CLymphomaPrognosisMultiple MyelomaFlow CytometryNeoplasmsFatal OutcomeCells, CulturedHodgkin DiseaseAntigens, CD34InfectionBone Neoplasms